Form 4GTBPCIK 0000109657

GT Biopharma, Inc.

Name: SEC EDGAR filing 0001641172-25-026893
Creator: GT Biopharma, Inc.
License: https://www.usa.gov/government-works

Insider transaction (Form 4) filed September 8, 2025.

Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners.

Read the filing on SEC.gov All documents in this filing

New to the Form 4? What it is and how to read one

Filing facts

Accession number: 0001641172-25-026893
Filer: GT Biopharma, Inc.
Ticker: GTBP
CIK: 0000109657
Form type: Form 4
Form description: Insider transaction
Filed at: September 8, 2025
Period of report: September 4, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 5.5 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from GT Biopharma, Inc.

See all 45 filings from GT Biopharma, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/109657/000164117225026893/0001641172-25-026893-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GT Biopharma, Inc. (0000109657) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.